Parasocialby Super Simple™

Communicable

CMI Communications

Subscribe in Parasocial

Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.

About

Communicable takes on hot topics in infectious diseases and clinical microbiology. Hosted by the editors of CMI Communications, the open-access journal of ESCMID, the European Society of Clinical Microbiology & Infectious Diseases.

Also on

Recent episodes

  • Communicable E65: Quarterly catch-up (October 2026 edition)Oct 18, 2026 · 49 min
  • Communicable E64: Getting micro on macrolides for community-acquired pneumoniaOct 4, 2026 · 50 min
  • Communicable E63: Does oseltamivir harm critically ill patients? The REMAP-CAP resultsSep 20, 2026 · 1 hr 3 min
  • Communicable E62: The 'prose' and cons of the POET trial – early oral antibiotic switch for endocarditisSep 6, 2026 · 52 min
  • Communicable E61: We will make you love PK/PD, part 3Aug 23, 2026 · 53 min
  • Communicable E60: Quarterly catch-up (August 2026 edition)Aug 9, 2026 · 49 min
  • Communicable E59: 'Ask me anything' – EUCAST and CLSI leadership explainJul 26, 2026 · 1 hr 9 min
  • Communicable E58: Reducing hospital-acquired pneumonia – the HAPPEN trial and how it happenedJul 12, 2026 · 54 min
  • Communicable E57: We will make you love PK/PD, part 2Jun 28, 2026 · 47 min
  • Communicable E56: Frequentist vs Bayesian for clinical trial analysis – 99% probability you’ll want to listen to thisJun 14, 2026 · 1 hr 5 min

RSS feed

Communicable | Parasocial